U.S. FDA Agent vs Facility Registration: What Foreign Manufacturers Mix Up in 2026

Alok Naik, MS- Regulatory Affairs

6 hours ago

7 min read

Every week a foreign manufacturer emails a U.S. consultant with the same sentence: "We need to register with FDA, please send the U.S. Agent form." The sentence contains two different filings, and the person writing it usually thinks they are one thing. That confusion is the single most common reason a first U.S. shipment slips by a quarter. This post is the decision tree we walk clients through before any paperwork starts, so you can see which filing your facility actually needs, in which order, and where the U.S. Agent fits.

Registration is a filing about your site. The U.S. Agent is a person named inside it.

FDA facility registration (for food it is called Food Facility Registration, for drugs and devices it is establishment registration) is a record FDA keeps about the physical site: who owns it, where it is, what it makes, and which activities it performs for the U.S. market. It is submitted through FDA's own portals, it carries an FDA-issued number, and it has a renewal cycle.

A U.S. Agent is not a filing. It is a person or firm physically located in the United States that a foreign facility designates as its point of contact with FDA. For food facilities the regulation defines the U.S. Agent as "a person residing or maintaining a place of business in the United States whom a foreign facility designates as its agent" (21 CFR 1.227). Drug and device rules say the same thing in their own words (21 CFR 207.69 and 21 CFR 807.40). All three add the same limitation: the agent cannot be a mailbox, an answering service, or any address where nobody is physically present.

So the relationship is simple once you see it. The registration is the file. The U.S. Agent is one of the mandatory fields in that file for a foreign site. That is why the two get mixed up, and also why treating them as interchangeable breaks the process.

Why you cannot do one without the other

For a foreign food, drug or device facility, the registration form itself asks for the U.S. Agent's name, address, phone and email. Under 21 CFR 1.232 a foreign food facility's registration has to include "the name, full address, phone number, and email address of the foreign facility's U.S. agent." Drug registrants "must designate a single United States agent" (21 CFR 207.69), and a foreign device establishment must name exactly one U.S. Agent when it registers (21 CFR 807.40). FDA's systems will not accept a foreign registration with that field empty, and for food facilities the agent has to confirm the appointment before FDA treats the registration as complete.

The reverse is also true. Appointing a U.S. Agent by itself creates nothing in FDA's database. If you have signed an agent agreement, paid for it, and stopped there, FDA still has no record of your site. We see this version of the mix-up more often than the first one: a manufacturer proudly tells a U.S. distributor that they "have an FDA agent" while their facility has never been registered.

The practical consequence is that the two are done together, in one sitting, and the agent appointment is the step that happens minutes before the registration is submitted, not months before or after.

The decision tree by product type

Start with what the product is under U.S. law, because the category decides which portal, which cycle, and which fees apply. The category is decided by intended use and claims, not by how the product is classified in your home country.

Food, beverages and dietary supplements

Dietary supplements are regulated as food in the United States, so a supplement plant follows the food pathway. A foreign facility that manufactures, processes, packs or holds food for U.S. consumption registers under 21 CFR 1.225 unless an exemption in 21 CFR 1.226 applies. The registration must name a U.S. Agent (21 CFR 1.232), and it is renewed every other year between October 1 and December 31 of even-numbered years (21 CFR 1.230). 2026 is a renewal year, so a facility registering for the first time this autumn should register inside that window rather than in September and then renew a month later. There is no FDA fee for food facility registration. Our separate guide covers every date, rule and trap of the 2026 food facility renewal, and the food facility registration service page explains how Axentra files it.

First step for this group: appoint the U.S. Agent and submit Food Facility Registration together. Product listing does not exist for conventional food; labeling compliance is a separate workstream.

Drugs, including OTC monograph products and APIs

A foreign establishment that manufactures, prepares, propagates, compounds or processes a drug offered for import into the U.S. registers under 21 CFR Part 207, lists each drug it ships, and designates a single U.S. Agent (21 CFR 207.69). Registration is done through FDA's electronic drug registration and listing system, requires a DUNS number, and results in an FDA Establishment Identifier for the site. Registration is renewed annually between October 1 and December 31, and listings are updated in June and December or whenever they change.

Two things routinely trip up first-time drug registrants. One, the U.S. Agent field and the importer field are different fields with different meanings; naming your U.S. Agent as your importer is a common error that surfaces at the port. Two, an OTC monograph drug facility also becomes liable for the annual OMUFA facility fee once it is registered, which is a budget line the export team rarely knows about.

First step for this group: obtain a DUNS number, appoint the U.S. Agent, then register the establishment and list the products in one submission cycle.

Medical devices

A foreign device establishment registers and lists through FDA's device registration and listing system and designates one U.S. Agent (21 CFR 807.40). Unlike food and drugs, device registration carries a mandatory annual establishment registration fee that FDA sets each fiscal year. For FY 2027, which runs October 1, 2026 through September 30, 2027, that fee is $13,785. The fee is paid before the registration is processed, so the budget approval has to land before the October to December registration window, not during it.

Device registration also has a role called the Official Correspondent, which is the person FDA contacts about the registration itself. The Official Correspondent can be anyone, including someone at the foreign site. The U.S. Agent must be in the United States. They can be the same firm, but they are two separate designations and both must be filled in.

First step for this group: confirm the device classification, secure the fee budget, appoint the U.S. Agent, then register and list.

Cosmetics

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) created a facility registration and product listing system for cosmetics, submitted through FDA's Cosmetics Direct portal. FDA's registration form asks a foreign cosmetic facility for U.S. Agent contact information, so a foreign brand that chooses to register goes through the same "agent named inside the filing" logic as the categories above. MoCRA also exempts certain small businesses from registration and listing, subject to product-type exceptions that FDA lists on its cosmetics pages. FDA has been clear that a cosmetic facility registration number "does not indicate FDA approval of the facility or its cosmetic products" and that FDA issues no certificate for it.

For cosmetics, the decision is therefore less about which filing comes first and more about whether the facility falls inside or outside MoCRA's scope and exemptions, and what the U.S. customer or marketplace expects to see. That is a conversation, not a form.

Three other roles people confuse with the U.S. Agent

The Importer of Record is the party that enters goods into U.S. commerce with Customs and carries the customs and duty liability. It is a trade role, not an FDA registration role, and a U.S. Agent does not automatically become your importer.

The Official Correspondent, described above, exists only in the device system and can sit outside the United States.

The Responsible Person, under MoCRA, is the manufacturer, packer or distributor whose name appears on the cosmetic label and who owns adverse event reporting and safety substantiation. A U.S. Agent is not a Responsible Person unless the label says so.

Naming one entity in all of these roles without understanding what each one signs up for is how a small consultancy ends up as the importer of record on a detained container. Ask any prospective agent which of these roles they are actually accepting.

What registration does not give you

A registration number is not an approval, a clearance, a licence or a certificate. FDA's rules go further and say that representing an establishment registration or registration number as FDA approval of a drug or device misbrands the product (21 CFR 207.77 and 21 CFR 807.39). The same principle applies to food and cosmetic registrations: FDA does not issue certificates confirming compliance, and any document claiming "FDA Registered" as if it were a quality mark is a marketing risk, not a credential.

What registration does give you is a legal basis to offer the product for import, a record FDA uses to schedule inspections, and a U.S. contact FDA can reach if something goes wrong with a shipment. That is valuable. It is just not what the sales deck sometimes says it is.

The order of operations for 2026

Confirm the U.S. product category first, because it decides everything downstream. Gather the facility identifiers next: legal name and address exactly as they appear on your export documents, a DUNS number for drug and device sites, and the list of activities the site performs. Appoint the U.S. Agent with a written agreement that says which roles are included and which are not. Then submit the registration, and for drugs and devices the listing, in the same working session so the agent field, the site record and the products line up on FDA's side on day one.

If your first shipment is targeted for early 2027, the timing works in your favour: the October to December window covers first-time food registration and the annual drug and device cycles at once, so one coordinated filing round sets the facility up for the year.

Axentra Global Pharma Compliance LLC acts as U.S. Agent for foreign food, supplement, cosmetic, drug and device facilities and files the registration alongside the appointment. The U.S. Agent and registration bundle starts at $299 per year per facility for food, dietary supplement and cosmetic sites; drug and device facilities are quoted on scope because of the fee and listing work involved. If you are not sure which pathway your product falls under, send us the label and the intended use and we will tell you which filing comes first.